Sectors

ENVB
Enveric Biosciences, Inc.
1.37
2 x 1.01
2 x 1.72
bid
ask
+
0.00
0.00%
2 @ 04:29 PM
1.37 +0.00 (0.00%)
Ytd-62.26%
1y-89.90%
1.33
day range
1.38
1.17
52 week range
13.63
Open1.38Prev Close1.37Low1.33High1.38Mkt Cap6.13M
Vol38.53KAvg Vol158.36KEPS-12.18P/EN/AForward P/E-0.22
Beta0.47Short Ratio0.31Inst. Own7.06%DividendN/ADiv YieldN/A
Ex Div Date04-23Earning08-1550-d Avg1.41200-d Avg2.851yr Est8.32
Income Statement
Operating Expenses3.03M
Research and Development Expense1.36M
Selling, General and Administrative Expense1.64M
Operating Income-3.03M
Interest Expense292.00
Net Income-3.03M
Net Income Common Stock-3.03M
Net Income Common Stock (USD)-3.03M
Consolidated Income-3.03M
Earnings per Basic Share-0.76
Earnings per Basic Share (USD)-0.76
Earnings per Diluted Share-0.76
Earning Before Interest & Taxes (EBIT)-3.03M
Earning Before Interest & Taxes (USD)-3.03M
Weighted Average Shares3.99M
Weighted Average Shares Diluted3.99M
Balance Sheet
Cash and Equivalents8.30M
Cash and Equivalents (USD)8.30M
Current Assets8.79M
Property, Plant & Equipment Net81.93K
Total Assets8.94M
Current Liabilities861.48K
Total Liabilities861.48K
Accumulated Retained Earnings (Deficit)-119.51M
Accumulated Other Comprehensive Income-594.68K
Shareholders Equity8.08M
Shareholders Equity (USD)8.08M
Assets Non-Current150.67K
Trade and Non-Trade Payables709.54K
Cash Flow
Depreciation, Amortization & Accretion36.83K
Net Cash Flow from Financing5.84M
Net Cash Flow / Change in Cash & Cash Equivalents3.39M
Issuance (Purchase) of Equity Shares5.86M
Net Cash Flow from Operations-2.44M
Effect of Exchange Rate Changes on Cash -12.93K
Share Based Compensation125.11K